Business Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO By Reuters - June 16, 2026 0 101 FacebookTwitterPinterestWhatsApp Novo Nordisk plans to seek Chinese regulatory approval for its weight-loss pill “very soon,” CEO Mike Doustdar said Tuesday, in a move to catch up with rival Eli Lilly in the world’s second-largest pharmaceutical market. Read more…